# Rivaroxaban or Aspirin for Biological Aortic Prosthesis

Study · id `cardio:ct-nct02974920` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02974920](<https://clinicaltrials.gov/study/NCT02974920>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02974920

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT02974920. Randomized; no masking; primary purpose prevention. Start 2017-01-01 (actual); primary completion 2022-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT02974920, source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)
- Started: 2017-01-01 (actual) (ClinicalTrials.gov record NCT02974920, source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)
- Primary completion: 2022-11-01 (anticipated) (ClinicalTrials.gov record NCT02974920, source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)
- Completion: 2022-11 (anticipated) (ClinicalTrials.gov record NCT02974920, source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02974920, source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02974920-2018-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rivaroxaban or Aspirin for Biological Aortic Prosthesis
- Condition: Aortic Stenosis
- Condition: Aortic Regurgitation
- Condition: Thrombosis
- Intervention (Drug): Rivaroxaban 10 MG
- Intervention (Drug): Aspirin
- Lead sponsor: Christian Torp-Pedersen
- Lead sponsor class: OTHER
- Collaborator: Aalborg University Hospital
- Collaborator class: OTHER
- Collaborator: Aarhus University Hospital
- Collaborator class: OTHER
- Collaborator: Odense University Hospital
- Collaborator class: OTHER
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as a collaborator: Aalborg University Hospital (`cardio:org-aalborg-university-hospital`)
- Registry lists this organization as a collaborator: Aarhus University Hospital (`cardio:org-aarhus-university-hospital`)
- Registry lists this organization as a collaborator: Odense University Hospital (`cardio:org-odense-university-hospital`)
- Registry lists this organization as a collaborator: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)

## Provenance

Content hash: 08b4217ce20509f83f3b8c930976c3b3dd6e0c153d8d25a8c44edbad9b89b22a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
